Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis
Condition: Breast Cancer Intervention: Drug: Inetetamab plus pyrotiniband and capecitabine Sponsor: Yan Xue Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Tucatinib With Brain and/or Spinal XRT in Patients With HER2+ Metastatic Breast Cancer and LMD
Conditions: HER2-positive Breast Cancer; LMD Interventions: Drug: Tucatinib 150 MG; Drug: Trastuzumab; Drug: Capecitabine; Radiation: Brain & Spinal Radiation Sponsors: Sunnybrook Health Sciences Centre; Seagen Inc.; Viatris Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer.
Condition: Advanced Gastric Carcinoma Interventions: Drug: Trastuzumab; Drug: Oxaliplatin; Drug: Capecitabine Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer
Condition: Recurrent or Metastatic Colorectal Cancer Intervention: Drug: Nelmastobart and Capecitabine Sponsor: Korea University Anam Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
